Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Hilton, Traci, Sanborn, Rachel, Boulmay, Brian, Li, Rui, Spieler, Bradley, Happel, Kyle, Paustian, Christopher, Moudgil, Tarsem, Dubay, Christopher, Fisher, Brenda, Mederos, Eileen, Ochoa, Augusto, Urba, Walter J, Hu, Hong-Ming, Fox, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292542/
http://dx.doi.org/10.1186/2051-1426-2-S3-P249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292542/
http://dx.doi.org/10.1186/2051-1426-2-S3-P249

Ejemplares similares